Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review. (2020)

First Author: Dambha-Miller H
Attributed to:  Epidemiological contribution to primary and secondary prevention of diabetes and obesity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.57440

Publication URI: https://www.repository.cam.ac.uk/handle/1810/310346

Type: Journal Article/Review